Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00881283 · ClinicalTrials.gov registry record
Long-term Cardiovascular Risk in Cured Cushing's Patients
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 1
- Enrollment target
NCT00881283: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT00881283 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00881283 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether subjects who have been affected by Cushing's disease in the past maintain some different characteristics compared with subjects who have never been diagnosed with the disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-09-08 |
| Est. Completion | 2010-03-30 |
Why NCT00881283 stopped before completion
NCT00881283 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00881283 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00881283 about?
NCT00881283 is a clinical study titled "Long-term Cardiovascular Risk in Cured Cushing's Patients". The purpose of this study is to determine whether subjects who have been affected by Cushing's disease in the past maintain some different characteristics compared with subjects who have never been diagnosed with the disease.
What is the current status of trial NCT00881283?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2008-09-08. Estimated completion is 2010-03-30.
Who is sponsoring clinical trial NCT00881283?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI